Expected in the first half of 2028, the planned separation would create a stand-alone retail pharmacy company with nearly 30,000 pharmacists.
|Podcasts|January 28, 2022
Pharmacist Moms: Coffee With Suzy - Episode 2
Suzanne Soliman, PharmD, BCMAS, discussed alcohol abuse and when the pharmacist becomes the patient with Sherry Price, PharmD, MBA, APh, BCPS, pharmacist and creator of the Drink Less Lifestyle podcast and program.
Advertisement
In the second episode of Coffee With Suzy, Suzanne Soliman, PharmD, BCMAS, discussed alcohol abuse and when the pharmacist becomes the patient with Sherry Price, PharmD, MBA, APh, BCPS, pharmacist and creator of the Drink Less Lifestyle podcast and program.
Advertisement
Related to this article
RSV hospitalization raised short-term invasive pneumococcal disease risk, especially among unvaccinated individuals.
ADA guidance ties monitoring choices to therapy, risk, and preference. Brooke Hudspeth, PharmD, explains how pharmacists help individualize the plan.
The provider-administered IL-23 inhibitor improved ACR20 response vs placebo after 2 doses in the phase 3 INSPIRE-1 and INSPIRE-2 trials.
Two Kidney Week 2026 posters suggest remnant cholesterol–based markers may help stratify CKD severity and cardiovascular death risk on hemodialysis.
Treated patients also had fewer post-acute hospitalizations and deaths, but individuals without risk factors saw no benefit.
A pharmacy technician reflects on 3 patient encounters that reshaped his
understanding of what a real patient requires.
In a Korean cohort of 1861 patients with nondialysis CKD, intake below 0.6 g/kg per day was linked to more kidney failure and higher all-cause mortality.
Advertisement
Advertisement
Trending on Pharmacy Times
1
CVS Health to Split Into 2 Public Companies, Separating Retail and Specialty Pharmacy
2
Community Pharmacists Guide Patients New to Glucose Monitoring
3
Is Less More? Comparing Metronidazole Dosing in Confirmed Anaerobic Infections
4
Two Gene Therapy Approvals Expand Options for Rare Immune Disorders as Access Challenges Persist
5